<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Reports of Biochemistry and Molecular Biology</title>
<title_fa></title_fa>
<short_title>rbmb.net</short_title>
<subject>Basic Sciences</subject>
<web_url>http://rbmb.net</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2322-3480</journal_id_issn>
<journal_id_issn_online>2322-3480</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/rbmb</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1400</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2022</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<volume>10</volume>
<number>4</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>The Impacts of Prepared Plasma-Activated Medium (PAM) Combined with Doxorubicin on the Viability of MCF-7 Breast Cancer Cells: A New Cancer Treatment Strategy</title>
	<subject_fa>بیوشیمی</subject_fa>
	<subject>Biochemistry</subject>
	<content_type_fa>مقالات اصلی</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;&lt;em&gt;Background:&lt;/em&gt;&lt;/strong&gt; For many years, the chemotherapeutic agent doxorubicin (DOX) has been used to treat&amp;nbsp;various cancers; however, DOX initiates several critical adverse effects. Many studies have reported that&amp;nbsp;non-thermal atmospheric pressure plasma can provide novel, but challenging, treatment strategies for cancer&amp;nbsp;patients. To date, tissues and cells have been treated with plasma-activated medium (PAM) as a practical&amp;nbsp;therapy. Consequently, due to the harmful adverse effects of DOX, we were motivated to elucidate the&amp;nbsp;impact of PAM in the presence of DOX on MCF-7 cell proliferation.&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;&lt;em&gt;Methods:&lt;/em&gt;&lt;/strong&gt; MTT assay, N-acetyl-L-cysteine (NAC) assay, and flow cytometry analysis were utilized&amp;nbsp;in this research.&amp;nbsp;&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;&lt;em&gt;Results:&lt;/em&gt;&lt;/strong&gt; The results demonstrated that 0.45 &amp;mu;M DOX combined with 3-min PAM significantly induced&amp;nbsp;apoptosis (p&lt; 0.01) through intracellular ROS generation in MCF-7 when compared with 0.45 &amp;mu;M DOX&amp;nbsp;alone or 3-min PAM alone. In contrast, after treatment with 0.45 &amp;mu;M DOX plus 4-min PAM, cell necrosis&amp;nbsp;was increased. Hence, DOX combined with 4-min PAM has cytotoxic effects with different mechanisms&amp;nbsp;than 4-min PAM alone, in which the number of apoptotic cells increases.&lt;br&gt;
&lt;br&gt;
&lt;strong&gt;&lt;em&gt;Conclusions:&lt;/em&gt;&lt;/strong&gt; Although further investigations are crucial, low doses of DOX plus 3-min PAM could&amp;nbsp;be a promising strategy for cancer therapy. The findings from this research may offer advantageous&amp;nbsp;and innovative clinical strategies for cancer therapy using PAM.&lt;/div&gt;
&lt;em&gt;&lt;span dir=&quot;RTL&quot;&gt;&lt;/span&gt;&lt;/em&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Apoptosis, Breast cancer lymphedema, Doxorubicin, Plasma-activated medium (PAM), Necrosis.</keyword>
	<start_page>640</start_page>
	<end_page>652</end_page>
	<web_url>http://rbmb.net/browse.php?a_code=A-10-763-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Setareh</first_name>
	<middle_name></middle_name>
	<last_name>Zahedian</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460012459</code>
	<orcid>100319475328460012459</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Azadeh</first_name>
	<middle_name></middle_name>
	<last_name>Hekmat</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>hekmat@ut.ac.ir.</email>
	<code>100319475328460012460</code>
	<orcid>100319475328460012460</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Saeed</first_name>
	<middle_name></middle_name>
	<last_name>Hesami Tackallou</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460012461</code>
	<orcid>100319475328460012461</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Biology, Central Tehran Branch, Islamic Azad University, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mahmood</first_name>
	<middle_name></middle_name>
	<last_name>Ghoranneviss</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460012462</code>
	<orcid>100319475328460012462</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Plasma Physics Research Center, Science and Research Branch, Islamic Azad University, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
